A Study of the Safety and Effectiveness of JNJ-16269110 (R256918) in Overweight and Obese Patients

Clinical trial NCT00622765 · COMPLETED

Trial details

NCT number: NCT00622765
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Obesity Nutritional and Metabolic Diseases Metabolic Diseases Nutrition Disorders Overweight

Start date: 2007-11-01
Primary completion: 2008-06-01
Enrollment: 321

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.